Smoldering Mantle Cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-20
Clinical Trial Update: Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating ibrutinib in untreated high-risk smoldering mantle cell lymphoma; the study is currently active but n…